Your browser doesn't support javascript.
loading
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Kileel, Emma M; Malvestutto, Carlos D; Lo, Janet; Fitch, Kathleen V; Fichtenbaum, Carl J; Aberg, Judith A; Zanni, Markella V; Martinez, Esteban; Okeke, Nwora Lance; Kumar, Princy; Joao, Esau; Bares, Sara H; Berrner, Daniel; Smieja, Marek; Roa, Jhoanna C; McCallum, Sara; Douglas, Pamela S; Ribaudo, Heather J; Grinspoon, Steven K.
Afiliação
  • Kileel EM; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Malvestutto CD; Division of Infectious Diseases, Ohio State University Medical Center, Columbus, Ohio, USA.
  • Lo J; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Fitch KV; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Fichtenbaum CJ; Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Aberg JA; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Zanni MV; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Martinez E; Infectious Diseases Service, Hospital Clinic and University of Barcelona, Barcelona, Spain.
  • Okeke NL; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.
  • Kumar P; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Joao E; Division of Infectious Diseases and Travel Medicine, Georgetown University School of Medicine, Washington, DC, USA.
  • Bares SH; Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
  • Berrner D; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Smieja M; University of California-San Francisco at Zuckerberg San Francisco General Hospital, San Francisco, California, USA.
  • Roa JC; Division of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
  • McCallum S; DLH Corporation, Silver Spring, Maryland, USA.
  • Douglas PS; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Ribaudo HJ; Duke University Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Grinspoon SK; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Clin Infect Dis ; 76(11): 2010-2013, 2023 06 08.
Article em En | MEDLINE | ID: mdl-36825498
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores de Integrase de HIV / Integrase de HIV Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores de Integrase de HIV / Integrase de HIV Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos